Shopping Cart
- Remove All
- Your shopping cart is currently empty
Nifeviroc (TD-0232) is an orally active CCR5 antagonist used in the study of HIV-1 infection.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $143 | In Stock | |
5 mg | $355 | In Stock | |
10 mg | $529 | In Stock | |
25 mg | $846 | In Stock | |
50 mg | $1,460 | In Stock | |
100 mg | $1,550 | In Stock |
Description | Nifeviroc (TD-0232) is an orally active CCR5 antagonist used in the study of HIV-1 infection. |
Targets&IC50 | CHO cells:2.9 nM |
In vitro | Nifeviroc is a specific HIV-1 entry inhibitor that works only by antagonizing CCR5 and not CXCR4. [1] |
Alias | TD-0232, TD0232 |
Molecular Weight | 590.71 |
Formula | C33H42N4O6 |
Cas No. | 934740-33-7 |
Smiles | O[C@@]1(C2=CC=CC=C2)[C@H](CN(C1)C(C3CCCC3)=O)CN4CCC(CC4)N(CC=C)C(OCC5=CC=C(C=C5)[N+]([O-])=O)=O |
Relative Density. | 1.28 g/cm3 (Predicted) |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (135.43 mM), Sonication is recommended. H2O: 80 mg/mL (135.43 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO/H2O
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.